Life Expectancy of Glial Tumors (Gliomas)

Glial tumors (gliomas) are complex tumors originating from glial cells located in the brain and spinal cord. These tumors may be either benign or malignant. Because the tumor type, stage, and response to treatment vary in each patient, life expectancy also differs from person to person.

With many years of experience in neurosurgery, Prof. Dr. Ömür Günaldı emphasizes that the most important factors affecting survival in glioma patients include the tumor grade, extent of surgical removal, genetic characteristics, and early diagnosis.

What Is a Glial Tumor (Glioma)?

Gliomas develop from glial cells, which provide support and nourishment to nerve cells. These cells help maintain the healthy functioning of brain tissue. However, when genetic mutations or uncontrolled cell proliferation occur, glial tumors may form.

Prof. Dr. Ömür Günaldı explains that gliomas are not a single type of brain tumor; instead, they are divided into several subgroups and grades, requiring individualized evaluation for each patient.

Gliomas are classified according to the cell type from which they originate:

Astrocytomas: Develop from astrocytes.

Oligodendrogliomas: Originate from oligodendrocytes.

Ependymomas: Arise from ependymal cells.

Each type has a different growth rate and response to treatment, which directly influences life expectancy.

Factors Affecting Life Expectancy in Glioma

Life expectancy for patients diagnosed with glioma depends on multiple factors, not only the tumor stage. Prof. Dr. Ömür Günaldı groups these factors into four main categories.

Tumor Grade

The World Health Organization (WHO) classifies gliomas from Grade I to Grade IV based on cellular differentiation.

Grade I–II (Low-Grade Gliomas):
These tumors grow slowly and are often considered benign. Long survival is possible after treatment.

Grade III–IV (High-Grade Gliomas):
These tumors are aggressive, grow rapidly, and invade surrounding tissues. Survival is generally shorter.

Prof. Dr. Ömür Günaldı states that patients with low-grade gliomas may live 10 years or longer, whereas survival in high-grade gliomas is typically shorter.

Extent of Surgical Removal

The amount of tumor removed during surgery significantly affects survival.

Complete removal can reduce recurrence risk in low-grade gliomas. In high-grade gliomas, even partial removal of a large portion of the tumor may extend survival.

Prof. Dr. Ömür Günaldı explains that modern microsurgical techniques and neuronavigation systems allow surgeons to remove tumors while preserving critical brain functions.

Genetic and Molecular Features

The genetic profile of gliomas plays an important role in understanding disease progression.

Patients with IDH mutations often have longer survival.

Oligodendrogliomas with 1p/19q deletion respond better to treatment.

Patients with MGMT methylation tend to respond better to chemotherapy.

According to Prof. Dr. Ömür Günaldı, molecular pathology analyses are now an essential part of treatment planning.

Age and Overall Health

Younger patients and those with good general health often respond better to treatment. As age increases and additional health problems appear, tolerance to treatment may decrease, affecting survival.

Life Expectancy in Low-Grade Gliomas

Low-grade gliomas generally include Grade I and Grade II tumors. These tumors grow slowly, spread minimally to surrounding tissues, and rarely metastasize.

Prof. Dr. Ömür Günaldı states that many patients in this group can live healthy lives for many years after surgical treatment.

Average Life Expectancy

Grade I Gliomas:
Survival of 15 years or more is possible.

Grade II Gliomas:
Average survival ranges between 8 and 12 years.

When these tumors are completely removed surgically, the risk of recurrence is relatively low. However, some low-grade gliomas may transform into higher-grade tumors over time. Therefore, regular MRI follow-up is essential.

Factors That Extend Survival

Complete surgical removal of the tumor
Presence of IDH mutation
Early diagnosis
Healthy lifestyle and nutrition
Regular neurological monitoring

Prof. Dr. Ömür Günaldı emphasizes that even low-grade gliomas must be monitored continuously because cellular changes may eventually make the tumor more aggressive.

Life Expectancy in High-Grade Gliomas

High-grade gliomas (Grade III–IV) are aggressive malignant tumors that grow rapidly and spread easily into surrounding brain tissue.

These tumors often cause symptoms quickly, such as headaches, seizures, personality changes, or confusion.

Prof. Dr. Ömür Günaldı states that early diagnosis is the most critical factor for improving survival in high-grade gliomas.

Average Life Expectancy

Grade III Gliomas (Anaplastic Astrocytoma):
Average survival is approximately 3–5 years.

Grade IV Gliomas (Glioblastoma Multiforme – GBM):
Average survival ranges between 12 and 24 months.

However, in patients with high surgical removal rates and favorable genetic markers such as IDH mutation, survival may extend up to 5 years or longer.

Treatments That Extend Survival

Surgical Treatment

Removing the largest possible portion of the tumor directly improves survival.

Prof. Dr. Ömür Günaldı explains that neuronavigation-assisted surgeries allow removal of tumors while preserving brain functions.

Radiotherapy

Radiotherapy is used after surgery to eliminate remaining tumor cells.

Chemotherapy

Drugs such as temozolomide are commonly used, especially in glioblastoma patients, to extend survival.

Targeted Therapy and Immunotherapy

New-generation treatments target tumor cells according to their genetic structure.

Prof. Dr. Ömür Günaldı states that personalized treatment approaches are producing promising results, particularly in high-grade gliomas.

Maintaining Quality of Life

Another important aspect besides survival is quality of life. During treatment, patients should maintain physical, mental, and emotional well-being.

Prof. Dr. Ömür Günaldı highlights the importance of a multidisciplinary approach, involving neurology, oncology, physiotherapy, and psychology.

Factors That Improve Quality of Life

Regular exercise and walking
Antioxidant-rich nutrition (vegetables, fruits, olive oil, green tea)
Stress management and psychological support
Regular sleep patterns
Mental activities that stimulate brain function

Nutrition plays a key role in strengthening the immune system. Prof. Dr. Ömür Günaldı recommends avoiding refined sugar and consuming natural foods.

Risk of Recurrence

Recurrence after treatment is always possible in gliomas, and this risk increases with tumor grade.

Low-grade gliomas: recurrence rate about 10–20%

High-grade gliomas: recurrence rate about 60–80%

Prof. Dr. Ömür Günaldı emphasizes that regular MRI monitoring after surgery allows early detection of recurrence and timely additional treatment.

Importance of Early Diagnosis

Early diagnosis is the most effective way to extend survival in glioma patients.

Symptoms such as headaches, seizures, balance problems, speech difficulties, or vision disturbances should not be ignored.

Prof. Dr. Ömür Günaldı emphasizes that brain MRI is crucial when such symptoms persist or worsen.

Low-grade gliomas detected at an early stage may be fully treatable, whereas late diagnosis in high-grade gliomas is associated with a poorer prognosis.

Follow-Up in Glioma Patients

After treatment, regular monitoring is necessary to extend survival and reduce recurrence risk.

According to Prof. Dr. Ömür Günaldı, the follow-up protocol generally includes:

MRI every 3–6 months during the first two years

Annual imaging afterward

Regular neurological examinations and cognitive assessments

Fatigue, memory difficulties, or emotional changes may occur after treatment, but these symptoms can often be improved through rehabilitation programs.

Recommendations for Extending Survival

Early diagnosis by paying attention to symptoms

Seeking treatment from experienced neurosurgeons

Choosing personalized treatments based on genetic analysis

Maintaining regular MRI and neurological follow-up

Adopting a healthy lifestyle including proper nutrition and stress management

Prof. Dr. Ömür Günaldı also states that maintaining an active lifestyle supports the immune system and contributes positively to treatment outcomes.

Glial tumors (gliomas) arise from the complex structure of brain tissue and may show both benign and malignant behavior.

Life expectancy varies depending on factors such as tumor grade, genetic characteristics, extent of surgical removal, and response to treatment.

Prof. Dr. Ömür Günaldı emphasizes that patients who receive early diagnosis and individualized treatment planning may achieve a longer and higher quality life.

For this reason, recognizing symptoms early, consulting experienced neurosurgeons, and maintaining regular follow-up after treatment are extremely important.

With early diagnosis, proper surgical intervention, and comprehensive treatment approaches, glioma has increasingly become a manageable disease.